Crossmark

Comparative analysis of enoxaparin versus rivaroxaban in the treatment of cancer associated venous thromboembolism: experience from a tertiary care cancer centre

Crossref DOI link: https://doi.org/10.1186/s12959-020-00221-2

Published Online: 2020-05-24

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Faqah, Anadil http://orcid.org/0000-0002-2581-5228
Sheikh, Hassan

Bakar, Muhammad Abu

Tayyaab, Fatima

Khawaja, Sahrish
License Information

Text and Data Mining valid from 2020-05-24

Version of Record valid from 2020-05-24
More Information

Article History

Received: 14 February 2020

Accepted: 7 May 2020

First Online: 24 May 2020

Ethics approval and consent to participate

: Study was approved by hospital’s IRB committee.

: Authors have consented for the publication.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below